Sastasundar Healthbuddy Approves Rs 100 Crore Share Buyback at Rs 493.21 Per Share
Sastasundar Healthbuddy Limited (SHBL), a material subsidiary of Sastasundar Ventures, has approved a share buyback program. The company plans to repurchase 20,27,534 fully paid-up equity shares at ₹493.21 per share, totaling ₹100 crore. The buyback is subject to shareholder approval. In response, Sastasundar Ventures has closed the trading window for designated persons and their immediate relatives, in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Sastasundar Ventures , through its material subsidiary Sastasundar Healthbuddy Limited (SHBL), has announced a significant share buyback program, demonstrating confidence in its financial position and commitment to enhancing shareholder value.
Buyback Details
The Board of Directors of Sastasundar Healthbuddy Limited approved a buyback proposal with the following key details:
Item | Detail |
---|---|
Number of shares to be repurchased | 20,27,534 fully paid-up equity shares |
Buyback price | Rs 493.21 per share |
Total buyback consideration | Rs 100.00 crore |
This strategic move is subject to shareholder approval from Sastasundar Healthbuddy Limited.
Regulatory Compliance and Trading Window
In compliance with regulatory requirements, Sastasundar Ventures has disclosed this material development to the stock exchanges. The company has implemented the following measures:
- The trading window for company securities will remain closed for designated persons and their immediate relatives.
- The closure is effective immediately and will continue until further notice.
This temporary restriction on trading aligns with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for preventing insider trading.
Impact and Outlook
The buyback initiative, valued at Rs 100.00 crore, signals the management's confidence in the company's future prospects and its commitment to returning value to shareholders. By reducing the number of outstanding shares, the buyback could potentially lead to improved earnings per share and overall shareholder value.
Investors and market participants will be closely watching the shareholder approval process and the subsequent execution of the buyback program. The move may also impact the stock price and trading volumes of Sastasundar Ventures, given SHBL's status as a material subsidiary.
As the healthcare and digital health sectors continue to evolve, Sastasundar Healthbuddy's strategic decisions will be crucial in shaping its market position and financial performance.
Historical Stock Returns for Sastasundar Ventures
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-1.14% | +2.56% | +13.09% | +30.82% | +2.88% | +254.74% |